NCT03525678 · Interventional trial
A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
Overall registry status Completed
Phase 2
Conditions Multiple Myeloma
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory